Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Hepatitis01:25

Hepatitis

86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

8.4K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

7.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

3.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cooperative Host-Guest Complexation in Densely Assembled Host Structures on Surfaces Revealed at the Single-Molecular Level.

Journal of the American Chemical Society·2026
Same author

Unravelling the chemodiversity of eggplants - Insight into their role in the underlying response to biotic and abiotic stresses.

Frontiers in plant science·2026
Same author

Production of <sup>64</sup>Cu and <sup>67</sup>Cu with accelerator neutrons by deuterons and their separation from zinc.

Frontiers in nuclear medicine·2025
Same author

Identification of anti-mouse PD-1 agonist antibodies that inhibit T cell activation.

Frontiers in immunology·2025
Same author

Electronic clinical decision support system guided blood culture stewardship in emergency departments: response to the national blood culture media shortage.

Infection control and hospital epidemiology·2025
Same author

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.

British journal of haematology·2025

Related Experiment Video

Updated: May 3, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

10.3K

Extracellular adenosine controls NKT-cell-dependent hepatitis induction.

Meenakshi Subramanian1, Radhika Kini, Manasa Madasu

  • 1New England Inflammation and Tissue Protection Institute, Northeastern University, Boston, MA, USA.

European Journal of Immunology
|January 23, 2014
PubMed
Summary
This summary is machine-generated.

Extracellular adenosine, acting through the A2A adenosine receptor (A2AR), suppresses NKT cell activation. This pathway is crucial for controlling NKT cell-triggered inflammation and preventing severe hepatitis.

Keywords:
A2A adenosine receptorAdenosineHepatitisImmunoregulationNKT cell

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

21.6K
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

8.0K

Related Experiment Videos

Last Updated: May 3, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

10.3K
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

21.6K
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

8.0K

Area of Science:

  • Immunology
  • Pharmacology
  • Hepatology

Background:

  • Extracellular adenosine regulates inflammation via the A2A adenosine receptor (A2AR).
  • A2AR deficiency exacerbates acute hepatitis, highlighting its role in immune regulation.
  • NKT cells are critical players in the pathogenesis of hepatitis.

Purpose of the Study:

  • To identify the immunoregulatory target of extracellular adenosine.
  • To investigate the role of the adenosine-A2AR pathway in controlling NKT cell activation and hepatitis.

Main Methods:

  • Administered A2AR agonist to mice undergoing Con A or α-galactosylceramide-induced hepatitis.
  • Analyzed NKT cell activation markers and cytokine production.
  • Compared hepatitis severity in A2AR-deficient and wild-type mice, including adoptive transfer experiments.

Main Results:

  • A2AR agonist treatment suppressed NKT cell activation and reduced hepatitis severity.
  • A2AR deficiency led to exaggerated hepatitis, indicating impaired NKT cell regulation.
  • Endogenous adenosine acting via A2AR physiologically controls NKT cell activation to limit inflammation.

Conclusions:

  • A2AR signaling is a key negative regulator of NKT cell activation.
  • The adenosine-A2AR pathway is critical for controlling NKT cell-mediated inflammatory responses, particularly in hepatitis.
  • Targeting the adenosine-A2AR pathway offers a potential strategy for managing inflammatory disorders involving NKT cells.